France RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

1.  Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.  Executive Summary

3.  Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.4.  Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for France RNAi Therapeutics Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Value Chain Analysis of France RNAi Therapeutics Market

3.7.  Competitive Landscape in France RNAi Therapeutics Market

4.  France RNAi Therapeutics Market by Type

4.1.  Small interfering RNA (siRNA)

4.2.  MicroRNA (miRNA)

5.  France RNAi Therapeutics Market by Application

5.1.  Genetic Disorders

5.2.  Oncology

5.3.  Neurodegenerative Disorders

5.4.  Infectious Diseases

5.5.  Renal Diseases

5.6.  Others

6.  France RNAi Therapeutics Market by Route of Administration

6.1.  Intradermal Injections

6.2.  Pulmonary Delivery

6.3.  Intravenous Injections

7.  France RNAi Therapeutics Market by End User

7.1.  Diagnostic Laboratories

7.2.  Research and Academic Laboratories

7.3.  Hospitals

8.  Company Profiles

8.1.  Company 1

8.2.  Company 2

8.3.  Company 3

8.4.  Company 4

8.5.  Company 5